News

Catch up on dermatology news, highlights, and insights from the past 24 hours.

The NEA’s Sam Iannotti, MPH, discusses how the Seal of Acceptance helps patients and clinicians identify products that meet rigorous eczema care standards.

Spesolimab effectively targets the IL-36 receptor, reducing inflammation and preventing flares in generalized pustular psoriasis, offering new hope for patients.

World Skin Health Day 2025 unites global leaders to advocate for skin health equity, emphasizing the urgent need for accessible dermatological care worldwide.

Artificial Intelligence (AI) enhances early detection of high-risk cutaneous squamous cell carcinoma (cSCC) by integrating advanced histopathological assessments for improved patient outcomes.

Jasper Therapeutics reveals promising results from briquilimab trials for chronic spontaneous urticaria, showcasing strong efficacy and safety despite manufacturing challenges.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Although bimekizumab carries a precaution for suicidal ideation and behavior, current data suggest it may improve mental health outcomes for patients with psoriasis.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

VYNE Therapeutics updates on VYN202, revealing promising early results in psoriasis treatment despite a clinical hold due to safety concerns.

Discover the latest advancements in laser treatments for acne vulgaris, focusing on diverse skin types and effective solutions for acne skin of color.

New 16-week data from the phase 2 APEX clinical trial demonstrated the anti-IL-13 antibody's efficacy across all key endpoints.

Explore the potential of whole-body cryotherapy as a novel, nonpharmacologic treatment for effectively managing atopic dermatitis symptoms.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

In case you missed it, this week we had news about the FDA's RPD Designation of QRX003 for Netherton Syndrome, Galderma's 2 new clinical trials of nemolizumab, Allergan Aesthetics' sPMA for SKINVIVE by Juvéderm, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Robin Smith, MD, MBA, discusses the future of regenerative aesthetics and her exosome-based skin care and hair care brand, Exoceuticals.

Delgocitinib ointment shows promise as an effective, well-tolerated treatment for atopic dermatitis on the face and neck, enhancing patient satisfaction and reducing adverse effects.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

A new paper highlights Alphyn Biologics' Zabalafin Hydrogel as a promising multitarget therapy for atopic dermatitis, addressing inflammation, itch, and bacterial complications.

E-learning enhances skin cancer detection by training professionals in optical coherence tomography (OCT) for accurate differentiation between basal cell carcinoma (BCC) and non-BCC lesions.

Anabela Cardoso, MD, reflects on specific data from the phase 3b ADmirable trial evaluating the safety and efficacy of lebrikizumab in patients with moderate to severe AD and pigmented skin.

Robin Smith, MD, MBA, champions exosome-powered skincare for long-lasting skin health and personalized regenerative aesthetics solutions for patients.

This review of the latest dermatologic studies includes insights into effectiveness and cost-effectiveness of treatments for psoriasis, bubble hair deformity induced by bathroom heating lamp, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Medical trainees face heightened burnout, especially in dermatology, due to COVID-19's impact on emotional exhaustion and personal accomplishment.

Discover how Robin Smith, MD, MBA, revolutionizes skin care with Exoceuticals, harnessing exosomes for advanced regenerative aesthetics and skin health solutions.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Incyte announces the 2024 Ingenuity Awards in Vitiligo recipients, empowering vitiligo advocates and enhancing patient care through innovative initiatives.